Palladium-catalyzed direct ortho-sulfonylation of azobenzenes with arylsulfonyl chlorides via C–H activation

Chengcai Xiaac, Zhenjiang Weic, Chao Shenb, Jun Xub, Yong Yanga, Weike Su*a and Pengfei Zhang*ab
aPharmacy College, Zhejiang University of Technology, Hangzhou 310014, China
bCollege of Material, Chemistry and Chemical Engineering, Hangzhou Normal University, Hangzhou 310036, China
cPharmacy College, Taishan Medical University, Tai'an 271016, China. E-mail: chxyzpf@hotmail.com; Fax: +86-571-28862867; Tel: +86-571-28862867

Received 11th April 2015 , Accepted 8th June 2015

First published on 8th June 2015


Abstract

A highly efficient and practical procedure to direct ortho-sulfonylation of azobenzenes' C–H bond with arylsulfonyl chlorides has been developed. The method was applicable to both electron-rich and electron-deficient substrates and delivered good yields for 21 examples. This reaction provides a convenient access to ortho-sulfonylated azobenzenes under mild conditions.


Introduction

Transition-metal-catalyzed C–C and C–heteroatom bond formation via C–H bond activation has been broadly explored because it is an efficient method to construct heterocyclic compounds.1 Recently, more and more effort has been made to develop many techniques to control the reaction selectivity by assistance of a directing group. Among them, examples such as 2-aryloxypyridines,2 quinoline N-oxide,3 arylpyrazoles,4 triazene azoxybenzenes,5 quinoline,6 and 2-aryl-1,2,3-triazoles group,7 etc. were proved to be versatile directing groups to obtain high regioselectivity on the ortho-C(sp2)–H bond. In recent years, azobenzenes have worked as a directing group to accelerate the C–H activation/functionalization process and have attracted more attention. For example, many groups have developed a palladium-catalyzed regioselective C–H bond activation of azoarenes and related compounds with alcohols,8 toluene,9 aldehydes,10 and α-oxocarboxylic acids11 to synthesize ortho-acylazoarenes. But, Sun and co-workers found that they obtained ortho-alkoxyazoarenes when PhI(OAc)2 was added as the oxidant in this reaction.12 Also, Hao and Li's group have developed a highly efficient method to synthesize diverse cinnolines and isoquinolines through the rhodium-catalyzed oxidative C–H activation of azobenzenes and ketazines with alkynes.13 Similarly, azobenzene derivatives such as ortho-acyloxyazoarenes,14 ortho-sulfonamideazoarenes,15 and ortho-arylazoarenes16 have been synthesized by this method.

Aryl sulfones have attracted considerable interest for they are essential components in medicinal chemistry,17 synthetic intermediates18 and advanced organic materials.19 The increasing applications of sulfones have stimulated investigations on development of efficient processes for the synthesis of these compounds. For example, Xu reported a method of palladium-catalyzed direct sulfonylation of 2-aryloxypyridines on the ortho-position of the benzene ring using 2-pyridyloxyl as the directing group and sulfonyl chlorides as sulfonylation reagents.20 Saidi has developed an efficient meta sulfonation of 2-phenylpyridines in the presence of ruthenium(II) complexes.21 Zhao disclosed a method of palladium-catalyzed direct sulfonylation of 2-arylpyridines on the ortho-position of the benzene ring using 2-arylpyridine as the directing group.22 Wu's group reported Pd(II)-catalyzed C–H sulfonylation of azobenzenes with arylsulfonyl chlorides using K2S2O8 as oxidant.23

As a part of our continuing efforts in C–H bond activation reactions, we have recently developed many methods to form C–S, and C–C bonds.24 Based on these findings, we develop a simple and efficient procedure for the synthesis of various ortho-sulfonylated azobenzenes via palladium-catalyzed direct cross-coupling of azobenzenes with arylsulfonyl chlorides.

Results and discussion

We initiated our investigation on the model reaction of azobenzene (1a) with p-tolylsulfonyl chloride (2a) to optimize the reaction parameters (Table 1). To our delight, the C2-sulfonylation took place in the presence of Pd(OAc)2 (10 mol%) and K2CO3 (2 equiv.) in DMSO under air for 12 h, affording compound 3a in 41% yield (entry 1, Table 1). Without catalyst, the reaction could not take place at all. Thus, PdCl2, [PdCl(allyl)]2, Pd(COD)Cl2, Pd(CH3CN)2Cl2, CuI and CuCl were tested to catalyze this reaction, in which Pd(CH3CN)2Cl2 gave the best result (entries 1–7, Table 1). K2CO3 was superior to other bases, such as Na2CO3, KOAc, NaOAc, CsCO3, NaHCO3 and KF (entries 8–13, Table 1). The solvent also played an important role in the reaction. Solvents such as DMF, NMP, CH3CN, 1,4-dioxane, toluene, and DMSO were screened, and 1,4-dioxane was found to be superior to the others (entries 5 and 14–18), affording 3a in 92% yield (entry 17, Table 1). The yield decreased to 73% when the catalyst loading was reduced to 5 mol% from 10 mol% (entry 19, Table 1). After surveying a variety of catalysts, bases, solvents, and catalyst loadings, we found that the combination of 10 mol% of Pd(CH3CN)2Cl2 and 2 equiv. of K2CO3 in 1,4-dioxane at 130 °C for 12 h served as the optimal conditions for this transformation. These results indicated that this transformation was facile and practical, as it did not require the use of strong bases, and the oxidants exclusion of air.
Table 1 Optimization of reaction conditionsa

image file: c5ra06474k-u1.tif

Entry Catalyst Base Solvent Yieldb (%)
a Reaction conditions: 1a (0.5 mmol), 2a (0.6 equiv.), catalyst (10 mol%), base (2.0 equiv.), 4A MS (100 mg) and solvent (2.0 mL) under air at 130 °C for 12 h, unless otherwise noted.b Isolated yields.c Pd(CH3CN)2Cl2 (5 mol%).
1 Pd(OAc)2 K2CO3 DMSO 41
2 PdCl2 K2CO3 DMSO 33
3 [PdCl(allyl)]2 K2CO3 DMSO 39
4 Pd(COD)Cl2 K2CO3 DMSO 15
5 Pd(CH3CN)2Cl2 K2CO3 DMSO 77
6 CuI K2CO3 DMSO N.R.
7 CuCl K2CO3 DMSO N.R.
8 Pd(CH3CN)2Cl2 Na2CO3 DMSO 40
9 Pd(CH3CN)2Cl2 KOAc DMSO 31
10 Pd(CH3CN)2Cl2 NaOAc DMSO 35
11 Pd(CH3CN)2Cl2 Cs2CO3 DMSO 44
12 Pd(CH3CN)2Cl2 NaHCO3 DMSO 23
13 Pd(CH3CN)2Cl2 KF DMSO 31
14 Pd(CH3CN)2Cl2 K2CO3 DMF 45
15 Pd(CH3CN)2Cl2 K2CO3 NMP 67
16 Pd(CH3CN)2Cl2 K2CO3 CH3CN 73
17 Pd(CH3CN)2Cl2 K2CO3 Dioxane 92
18 Pd(CH3CN)2Cl2 K2CO3 Toluene 21
19 Pd(CH3CN)2Cl2 K2CO3 Dioxan 73c


With the optimized reaction conditions in hand, the reactivities of different arylsulfonyl chlorides as the sulfonylation reagents were investigated. The results are revealed in Table 2, the C–H sulfonylation of azobenzene (1a) with arylsulfonyl chlorides could proceed smoothly and furnish the corresponding ortho-substituted products 3a–n in 63–92% yields (Table 2, entries 1–14). The substrates with a para-electron-donating group afforded the products 3a, 3g, 3n in excellent yields (92%, 84% and 91%). When arylsulfonyl chlorides were substituted at the para position with a electron-withdrawing group (such as 4-F, 4-Br, 4-methoxy, 4-Cl groups) there also afforded the products 3b, 3c, 3d and 3m in good yields (75–86%). But the substrates with a strong electron-withdrawing group (–NO2) on para and meta position provided the corresponding product 3d, 3f in low yields (67%, 63%). Heteroarysulfonyl chlorides, such as 3,5-dimethyl-isoxazole-4-sulfonyl chloride, thiophene-2-sulfonyl chloride, 5-chloro-3-methylbenzo[b]thiophene-2-sulfonyl chloride, and methyl 2-(chlorosulfonyl)thiophene-3-carboxylate were tested as the substrates. The corresponding ortho-sulfonylation products 3h, 3i, 3j, and 3k were obtained in good yields (73–90%).

Table 2 Preparation of sulfones from various sulfinatesa

image file: c5ra06474k-u2.tif

Entry Sulfinates Product Yieldb (%)
a Reaction conditions: 1a (0.5 mmol), 2 (0.6 equiv.), catalyst (10 mol%), base (2.0 equiv.), 4A MS (100 mg) and solvent (2.0 mL) under air at 130 °C for 12 h, unless otherwise noted.b Isolated yields.
1 image file: c5ra06474k-u3.tif image file: c5ra06474k-u4.tif 92
2 image file: c5ra06474k-u5.tif image file: c5ra06474k-u6.tif 76
3 image file: c5ra06474k-u7.tif image file: c5ra06474k-u8.tif 86
4 image file: c5ra06474k-u9.tif image file: c5ra06474k-u10.tif 67
5 image file: c5ra06474k-u11.tif image file: c5ra06474k-u12.tif 75
6 image file: c5ra06474k-u13.tif image file: c5ra06474k-u14.tif 63
7 image file: c5ra06474k-u15.tif image file: c5ra06474k-u16.tif 84
8 image file: c5ra06474k-u17.tif image file: c5ra06474k-u18.tif 90
9 image file: c5ra06474k-u19.tif image file: c5ra06474k-u20.tif 87
10 image file: c5ra06474k-u21.tif image file: c5ra06474k-u22.tif 89
11 image file: c5ra06474k-u23.tif image file: c5ra06474k-u24.tif 73
12 image file: c5ra06474k-u25.tif image file: c5ra06474k-u26.tif 90
13 image file: c5ra06474k-u27.tif image file: c5ra06474k-u28.tif 82
14 image file: c5ra06474k-u29.tif image file: c5ra06474k-u30.tif 91


After screening of different arylsulfonyl chlorides, we explored the scope of differently substituted azobenzenes. Representative azoxybenzenes were firstly synthesized and examined. The results are shown in Table 3. It was found that these electron-rich azobenzenes gave higher yields than those electron-deficient azobenzenes. For instance, the reactions of 4,4′-dimethyl-azoxybenzene, 3,3′-dimethylazoxybenzene, 4,4′-di methoxy azoxybenzene, 3,3′-di methoxy azoxybenzene, provided the corresponding products in 75–86% yields (3o–3r). The reactions of unsymmetrical azobenzenes also proceeded smoothly and gave the products which could be determined by 1H NMR, were obtained in good yields (71% for 3t; 78% for 3u, respectively).

Table 3 Preparation of sulfones from various azoarenesa

image file: c5ra06474k-u31.tif

Entry Azoarenes Product Yieldb (%)
a Reaction conditions: 1a (0.5 mmol), 2 (0.6 equiv.), catalyst (10 mol%), base (2.0 equiv.), 4A MS (100 mg) and solvent (2.0 mL) under air at 130 °C for 12 h, unless otherwise noted.b Isolated yields.
1 image file: c5ra06474k-u32.tif image file: c5ra06474k-u33.tif 86
2 image file: c5ra06474k-u34.tif image file: c5ra06474k-u35.tif 75
3 image file: c5ra06474k-u36.tif image file: c5ra06474k-u37.tif 83
4 image file: c5ra06474k-u38.tif image file: c5ra06474k-u39.tif 85
5 image file: c5ra06474k-u40.tif image file: c5ra06474k-u41.tif 15
6 image file: c5ra06474k-u42.tif 71
7 image file: c5ra06474k-u43.tif image file: c5ra06474k-u44.tif 81


A single crystal of 3b was obtained from trichloromethane. Its crystal structure (Fig. 1) exhibited that such palladium-catalyzed direct sulfonylation of azobenzene on the ortho-position. The crystal data, refinement parameters, bond lengths and bond angles are given in the Table S1.


image file: c5ra06474k-f1.tif
Fig. 1 ORTEP diagram of catalyst 3b showing atom labelling scheme. Hydrogen atoms are omitted for clarity. Thermal ellipsoids are drawn at 30% probability.

In addition, when some radical scavengers such as TEMPO (2,2,6,6-tetramethyl-1-piperidinyloxy) or HQ (hydroquinone) were used in this C–S coupling reaction, the reaction can be carried out smoothly. So this experiment can exclude the free radical mechanism. On the basis of these results and other previous related studies,19–22 a plausible reaction mechanism of this palladium-catalyzed sulfonylation of an azobenzene compounds is proposed, as shown in Scheme 1. Step (i), azobenzene 1a firstly reacts with Pd(CH3CN)2Cl2 to form a cyclopalladated(II) intermediate through ortho-C–H bond insertion. In step (ii), the sulfonylation could go through a direct displacement-type reaction to give the final product 3a. Meanwhile, the Pd(II) was regenerated for the next catalytic cycle.


image file: c5ra06474k-s1.tif
Scheme 1 Plausible reaction mechanism.

Conclusions

In conclusion, we have developed a palladium-catalyzed direct C(sp2)–H sulfonylation of azobenzene with arylsulfonyl Chlorides. The reaction exhibits a good tolerance for a broad range of general functional groups. The present work demonstrated the utility of azobenzene as a removable directing group through the direct C–H bond activation/functionalization and deprotecting group to form ortho-sulfonylated azobenzenes.

Experimental section

General information

All reactions were run under argon in Schlenk tubes using vacuum lines. DMF, NMP, CH3CN, 1,4-dioxane, toluene, and DMSO, analytical grade were not distilled before use. Commercial arylsulfonyl chlorides and azobenzenes were used without purification. 1H NMR, 13C NMR spectra were recorded using a 500 MHz spectrometer in CDCl3 and DMSO with shifts referenced to SiMe4 (δ = 0). IR spectra were recorded on an FTIR spectrophotometer. Melting points were determined by using a local hot-stage melting point apparatus and are uncorrected. Elemental analyses were carried out on a CHN analyzer. Mass spectra were recorded using LC-MS and HRMS (ESI-TOF analyzer) equipment.

General procedure for preparation of azoxybenzenes

All of the azo-compounds were prepared from arylamines, according to the literature.1 Mix CuBr (4.2 mg, 0.03 mmol), pyridine (8.7 mg, 0.09 mmol), arylamines (93 mg, 1 mmol) in toluene (4 mL) under air (1 atm). The reaction mixture was vigorously stirred at 60 °C for 20 h. After cooling down to room temperature and concentrating in vacuum, the residue was purified by flash chromatography on a short silica gel (eluent: petroleum ether) to afford azo-compound.

General procedure for palladium-catalyzed direct ortho-sulfonylation of azobenzenes with arylsulfonyl chlorides via C–H activation

Mix azoic compound (0.5 equiv.), benzene sulfonyl chloride (0.6 equiv.), Pd(CH3CN)2Cl2 (10 mol%), K2CO3 (2 equiv.), 4A MS (100 mg) in 1,4-dioxane (2 mL) under air. The reaction mixture was vigorously stirred at 130 °C for 12 h. After cooling down to room temperature and concentrating in vacuum, the residue was purified by flash chromatography on a short silica gel to afford corresponding product.

Diazene (1a)1

(E)-1,2-Di-p-tolyldiazene. Obtained as a yellow solid in 90% yield; M.p. 138–140 °C. 1H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 8.3 Hz, 4H), 7.30 (d, J = 8.0 Hz, 4H), 2.42 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 150.85, 141.22, 129.73, 122.75, 21.50. HRMS (ESI+): calculated for C14H14N2: [M + H]+ 211.123, found 211.1032.
(E)-1,2-Di-m-tolyldiazene. Obtained as a yellow solid in 87% yield; M.p. 123–124 °C. 1H NMR (500 MHz, CDCl3) δ 7.71 (s, 4H), 7.40–7.34 (m, 2H), 7.25 (d, J = 7.0 Hz, 2H), 2.42 (d, J = 3.0 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 152.87, 139.00, 131.75, 128.95, 122.97, 120.54, 21.43. HRMS (ESI+): calculated for C14H14N2: [M + H]+ 211.123, found 211.1034.
(E)-1,2-Bis(4-ethoxyphenyl)diazene. Obtained as a yellow solid in 92% yield; M.p. 150–151 °C. 1H NMR (500 MHz, CDCl3) δ 7.91–7.82 (m, 4H), 6.98 (d, J = 8.9 Hz, 4H), 4.10 (q, J = 7.0 Hz, 4H), 1.44 (t, J = 7.0 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 161.01, 146.93, 124.36, 114.66, 63.79, 14.80. HRMS (ESI+): calculated for C16H18N2O2: [M + H]+ 270.1368, found 271.1373.
(E)-1,2-Bis(3-methoxyphenyl)diazene. Obtained as a yellow solid in 85% yield; M.p. 70–71 °C. 1H NMR (500 MHz, CDCl3) δ 7.49 (ddd, J = 7.8, 1.6, 0.9 Hz, 2H), 7.40–7.37 (m, 2H), 7.36 (t, J = 8.0 Hz, 2H), 6.98 (ddd, J = 8.2, 2.6, 0.8 Hz, 2H), 3.83 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 159.31, 152.79, 128.76, 116.85, 116.14, 104.69, 54.46. HRMS (ESI+): calculated for C14H14N2O2: [M + H]+ 243.1128, found 243.0686.
(E)-1-(3-Methoxyphenyl)-2-phenyldiazene. Obtained as a yellow solid in 60% yield; M.p.30–31 °C. 1H NMR (500 MHz, CDCl3) δ 7.95–7.89 (m, 2H), 7.57–7.41 (m, 6H), 7.07–7.02 (m, 1H), 3.90 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 160.34, 153.91, 152.61, 131.05, 129.80, 129.11, 122.89, 117.83, 117.14, 105.74, 55.50. HRMS (ESI+): calculated for C13H12N2O1: [M + H]+ 213.1022, found 213.061.
(E)-1-(3-Methoxyphenyl)-2-(m-tolyl)diazene. Obtained as a yellow liquid in 58% yield. 1H NMR (500 MHz, CDCl3) δ 7.73 (d, J = 5.8 Hz, 2H), 7.55 (ddd, J = 7.8, 1.5, 1.0 Hz, 1H), 7.46–7.44 (m, 1H), 7.41 (dd, J = 16.4, 8.3 Hz, 2H), 7.29 (d, J = 7.5 Hz, 1H), 7.03 (ddd, J = 8.2, 2.6, 0.8 Hz, 1H), 3.89 (s, 3H), 2.45 (s, 3H), 2.45 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 160.32, 153.94, 152.68, 138.99, 131.83, 129.76, 128.91, 122.93, 120.55, 117.72, 117.04, 105.69, 55.47, 21.37. HRMS (ESI+): calculated for C14H14N2O1: [M + H]+ 227.1179, found 227.075.
(E)-1-Phenyl-2-(2-tosylphenyl)diazene (3a). Obtained as a white solid in 78% yield; M.p. 157–158 °C. 1H NMR (500 MHz, CDCl3) δ 8.40 (dd, J = 7.7, 1.5 Hz, 1H), 7.86–7.80 (m, 4H), 7.65 (dtd, J = 22.0, 7.5, 1.4 Hz, 2H), 7.58 (dd, J = 7.7, 1.3 Hz, 1H), 7.55–7.50 (m, 3H), 7.16 (d, J = 8.2 Hz, 2H), 2.32 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 152.72, 149.07, 143.91, 139.43, 138.88, 134.35, 131.97, 130.54, 129.35, 129.29, 129.11, 128.20, 123.77, 116.90, 21.51. HRMS (ESI+): calculated for C23H18N2O3S: [M + H]+ 336.0916, found 337.0989.
(E)-1-(2-((4-Bromophenyl)sulfonyl)phenyl)-2-phenyldiazene (3b). Obtained as a orange solid in 66% yield; M.p. 200–201 °C. 1H NMR (500 MHz, CDCl3) δ 8.39 (d, J = 7.8 Hz, 1H), 7.84–7.78 (m, 4H), 7.71 (t, J = 7.6 Hz, 1H), 7.65 (t, J = 7.5 Hz, 1H), 7.60 (d, J = 7.8 Hz, 1H), 7.56–7.52 (m, 3H), 7.52–7.48 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 152.68, 148.96, 141.34, 138.17, 134.82, 132.20, 131.96, 130.71, 129.78, 129.42, 129.23, 128.20, 123.67, 117.06. HRMS (ESI+): calculated for C18H13BrN2O2S: [M + Na]+ 422.9773, found 422.9178.
(E)-1-(2-((4-Fluorophenyl)sulfonyl)phenyl)-2-phenyldiazene (3c). Obtained as a orange solid in 86% yield; M.p. 107–108 °C. 1H NMR (500 MHz, CDCl3) δ 8.40 (dd, J = 7.8, 1.4 Hz, 1H), 8.00–7.95 (m, 2H), 7.83–7.79 (m, 2H), 7.70 (dd, J = 7.7, 1.5 Hz, 1H), 7.65 (td, J = 7.6, 1.4 Hz, 1H), 7.60 (dd, J = 7.8, 1.3 Hz, 1H), 7.57–7.53 (m, 3H), 7.03 (t, J = 8.6 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 152.69, 148.95, 138.43, 134.70, 132.16, 131.12, 131.05, 130.67, 129.35, 129.21, 123.66, 117.04, 116.01, 115.83. HRMS (ESI+): calculated for C18H13FN2O2S: [M + Na]+ 341.0755, found 341.0211.
(E)-1-(2-((4-Nitrophenyl)sulfonyl)phenyl)-2-phenyldiazene (3d). Obtained as a pale yellow solid in 67% yield; M.p. 134–135 °C. 1H NMR (500 MHz, CDCl3) δ 8.44 (d, J = 7.8 Hz, 1H), 8.19 (d, J = 8.2 Hz, 2H), 8.13 (d, J = 8.5 Hz, 2H), 7.74 (qd, J = 15.1, 7.5 Hz, 4H), 7.65 (d, J = 7.9 Hz, 1H), 7.55 (d, J = 5.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 152.57, 150.15, 148.90, 148.06, 137.29, 135.42, 132.50, 130.92, 129.65, 129.36, 123.90, 123.57, 117.21. HRMS (ESI+): calculated for C18H13N3O4S: [M + H]+ 368.07, found 368.0128.
(E)-1-(2-((4-Methoxyphenyl)sulfonyl)phenyl)-2-phenyldiazene (3e). Obtained as a white solid in 75% yield; M.p. 139–140 °C. 1H NMR (500 MHz, CDCl3) δ 8.37 (d, J = 7.7 Hz, 1H), 7.87 (dd, J = 20.9, 6.6 Hz, 4H), 7.64 (dt, J = 21.9, 7.4 Hz, 2H), 7.55 (dd, J = 12.8, 6.5 Hz, 4H), 6.82 (d, J = 8.4 Hz, 2H), 3.76 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 163.21, 152.75, 149.02, 139.16, 134.23, 133.81, 131.95, 130.54, 129.16, 123.75, 116.92, 113.87, 55.57. HRMS (ESI+): calculated for C19H16N2O3S: [M + H]+ 353.0954, found 4353.0419.
(E)-1-(2-((3-Nitrophenyl)sulfonyl)phenyl)-2-phenyldiazene (3f). Obtained as a yellow solid in 63% yield; M.p. 162–163 °C. 1H NMR (500 MHz, CDCl3) δ 8.92 (s, 1H), 8.46 (d, J = 7.8 Hz, 1H), 8.32 (d, J = 8.1 Hz, 1H), 8.23 (d, J = 7.8 Hz, 1H), 7.79 (dd, J = 3.1, 2.1 Hz, 2H), 7.77–7.68 (m, 2H), 7.64 (d, J = 7.8 Hz, 1H), 7.56 (ddd, J = 9.7, 5.2, 4.3 Hz, 4H). 13C NMR (126 MHz, CDCl3) δ 152.48, 148.85, 147.95, 144.55, 137.37, 135.39, 133.71, 132.55, 130.89, 130.09, 129.61, 129.39, 127.50, 123.75, 123.59, 117.29. HRMS (ESI+): calculated for C18H13N3O4S: [M + H]+ 368.07, found 368.0146.
(E)-1-(2-(Naphthalen-2-ylsulfonyl)phenyl)-2-phenyldiazene (3g). Obtained as a pale yellow solid in 84% yield; M.p. 139–140 °C. 1H NMR (500 MHz, CDCl3) δ 8.64 (s, 1H), 8.64 (s, 1H), 8.57–8.44 (m, 1H), 8.57–8.46 (m, 1H), 7.86 (dd, J = 22.7, 8.8 Hz, 3H), 7.78 (d, J = 8.1 Hz, 3H), 7.70 (ddd, J = 9.2, 6.0, 1.8 Hz, 2H), 7.64–7.57 (m, 2H), 7.57–7.47 (m, 4H). 13C NMR (126 MHz, CDCl3) δ 152.72, 149.00, 138.98, 138.59, 134.97, 134.59, 132.01, 131.95, 130.63, 130.19, 129.46, 129.17, 129.11, 128.96, 127.87, 127.36, 123.76, 123.03, 116.89. HRMS (ESI+): calculated for C22H16N2O2S: [M + H]+ 373.1005, found 373.0445.
(E)-3,5-Dimethyl-4-((2-(phenyldiazenyl)phenyl)sulfonyl)isoxazole (3h). Obtained as a white solid in 90% yield; M.p. 101–102 °C. 1H NMR (500 MHz, CDCl3) δ 8.37 (d, J = 7.9 Hz, 1H), 7.77 (t, J = 7.6 Hz, 1H), 7.73–7.65 (m, 3H), 7.56 (dd, J = 12.3, 7.0 Hz, 4H), 2.50 (s, 3H), 2.19 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 174.00, 157.64, 152.98, 149.64, 137.80, 135.01, 132.19, 130.43, 129.24, 129.13, 123.30, 117.89, 117.64, 13.04, 10.81. HRMS (ESI+): calculated for C17H15N3O3S: [M + H]+ 342.0907, found 342.0377.
(E)-1-Phenyl-2-(2-(thiophen-2-ylsulfonyl)phenyl)diazene (3i). Obtained as a white solid in 87% yield; M.p. 100–101 °C. 1H NMR (500 MHz, CDCl3) δ 8.37 (d, J = 8.0 Hz, 1H), 8.06–7.98 (m, 2H), 7.82–7.77 (m, 1H), 7.76–7.69 (m, 2H), 7.68–7.63 (m, 1H), 7.63–7.53 (m, 4H), 7.00 (t, J = 4.4 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 152.67, 149.00, 143.44, 139.35, 134.53, 134.38, 134.06, 132.12, 130.82, 129.25, 129.21, 127.23, 124.09, 116.89. HRMS (ESI+): calculated for C16H12N2O2S2: [M + H]+ 329.0413, found 329.0336.
(E)-1-(2-((5-Chloro-3-methylbenzo[b]thiophen-2-yl)sulfonyl)phenyl)-2-phenyldiazene (3j). Obtained as a pale yellow solid in 89% yield; M.p. 156–157 °C. 1H NMR (500 MHz, CDCl3) δ 8.45 (d, J = 7.7 Hz, 1H), 7.87 (d, J = 7.5 Hz, 1H), 7.76 (t, J = 7.6 Hz, 1H), 7.73–7.63 (m, 1H), 7.52 (q, J = 5.3 Hz, 1H), 7.38 (d, J = 8.7 Hz, 1H), 2.51 (d, J = 0.6 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 152.46, 149.41, 140.55, 139.83, 138.46, 137.09, 134.91, 132.15, 131.31, 130.53, 129.58, 128.98, 127.89, 124.12, 123.63, 123.21, 117.17, 12.35. HRMS (ESI+): calculated for C21H15N2O2S2: [M + H]+ 427.0336, found 426.9721.
(E)-Methyl3-((2-(phenyldiazenyl)phenyl)sulfonyl)thiophene-2-carboxylate (3k). Obtained as a pale yellow solid in 73% yield; M.p. 92–93 °C. 1H NMR (500 MHz, CDCl3) δ 8.54 (dd, J = 5.6, 3.6 Hz, 1H), 7.85 (d, J = 5.2 Hz, 1H), 7.79–7.71 (m, 1H), 7.68–7.61 (m, 1H), 7.49 (d, J = 7.6 Hz, 1H), 7.39 (d, J = 5.3 Hz, 1H), 3.71 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 159.44, 154.45, 152.40, 151.33, 146.00, 145.89, 139.06, 134.18, 132.02, 131.79, 130.11, 130.09, 128.90, 123.69, 116.34, 52.59. HRMS (ESI+): calculated for C18H14N2O4S2: [M + H]+ 387.0468, found 386.9885.
(E)-1-Phenyl-2-(2-(phenylsulfonyl)phenyl)diazene (3l). Obtained as a orange solid in 90% yield; M.p. 149–150 °C. 1H NMR (500 MHz, CDCl3) δ 8.43 (dd, J = 7.8, 1.5 Hz, 1H), 7.95 (dt, J = 6.3, 2.0 Hz, 2H), 7.83–7.75 (m, 2H), 7.68 (dtd, J = 22.5, 7.5, 1.5 Hz, 2H), 7.62–7.58 (m, 1H), 7.54–7.50 (m, 3H), 7.49–7.45 (m, 1H), 7.37 (dd, J = 10.6, 4.9 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 146.56, 143.29, 142.32, 138.53, 134.56, 132.96, 132.04, 130.59, 129.46, 129.11, 128.66, 128.05, 123.77, 116.92. HRMS (ESI+): calculated for C18H14N2O4S2: [M + H]+ 356.0395, found 357.0432.
(E)-1-(2-((4-Chlorophenyl)sulfonyl)phenyl)-2-phenyldiazene (3m). Obtained as a orange solid in 82% yield; M.p. 170–171 °C. 1H NMR (500 MHz, CDCl3) δ 8.40 (dd, J = 7.8, 1.4 Hz, 1H), 7.93–7.86 (m, 2H), 7.84–7.76 (m, 2H), 7.71 (td, J = 7.6, 1.5 Hz, 1H), 7.65 (td, J = 7.6, 1.4 Hz, 1H), 7.63–7.58 (m, 1H), 7.57–7.51 (m, 3H), 7.37–7.30 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 152.65, 148.94, 140.76, 139.61, 138.19, 134.79, 132.17, 130.68, 129.69, 129.40, 129.20, 128.95, 123.65, 117.03. HRMS (ESI+): calculated for C18H14N2O4S2: [M + H]+ 322.0776, found 323.0832.
(E)-1-(2-((4-(tert-Butyl)phenyl)sulfonyl)phenyl)-2-phenyldiazene (3n). Obtained as a orange solid in 91% yield; M.p. 140–141 °C. 1H NMR (500 MHz, CDCl3) δ 8.41 (dd, J = 7.7, 1.5 Hz, 1H), 7.87–7.83 (m, 2H), 7.81–7.74 (m, 2H), 7.70–7.60 (m, 2H), 7.57–7.54 (m, 1H), 7.53–7.49 (m, 3H), 7.38–7.32 (m, 2H), 1.22 (d, J = 3.3 Hz, 9H). 13C NMR (126 MHz, CDCl3) δ 156.81, 152.66, 149.13, 139.31, 138.77, 134.40, 131.98, 130.54, 129.28, 129.07, 127.89, 125.71, 123.78, 116.92, 35.08, 31.00. HRMS (ESI+): calculated for C18H14N2O4S2: [M + H]+ 378.1402, found 379.1446.
(E)-1-(4-Methyl-2-tosylphenyl)-2-(p-tolyl)diazene (3o). Obtained as a orange solid in 86% yield; M.p. 174–175 °C. 1H NMR (500 MHz, CDCl3) δ 8.23 (s, 1H), 7.87 (d, J = 8.3 Hz, 2H), 7.74 (d, J = 8.2 Hz, 2H), 7.55 (d, J = 8.1 Hz, 1H), 7.47 (dd, J = 8.1, 1.1 Hz, 1H), 7.33 (d, J = 8.1 Hz, 2H), 7.19 (d, J = 8.1 Hz, 2H), 2.54 (s, 3H), 2.48 (s, 3H), 2.34 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 150.91, 147.03, 143.72, 142.46, 141.26, 139.60, 138.53, 134.88, 129.73, 129.62, 129.23, 128.14, 123.73, 116.73, 21.61, 21.53, 21.45. HRMS (ESI+): calculated for C21H20N2O2S: [M + H]+ 365.1318, found 365.076.
(E)-1-(5-Methyl-2-tosylphenyl)-2-(m-tolyl)diazene (3p). Obtained as a white solid in 75% yield; M.p. 96–97 °C. 1H NMR (500 MHz, CDCl3) δ 8.30 (d, J = 8.1 Hz, 1H), 7.86 (d, J = 8.3 Hz, 2H), 7.67 (d, J = 7.9 Hz, 1H), 7.60 (s, 1H), 7.48–7.40 (m, 2H), 7.40–7.32 (m, 2H), 7.20 (d, J = 8.1 Hz, 2H), 2.48 (d, J = 10.1 Hz, 6H), 2.35 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 152.80, 149.06, 145.57, 143.66, 139.72, 138.95, 135.91, 132.69, 130.96, 129.45, 129.24, 128.92, 128.04, 123.82, 121.45, 117.18, 21.62, 21.54, 21.38. HRMS (ESI+): calculated for C21H20N2O2S: [M + H]+ 365.1318, found 365.0756.
(E)-1-(4-Ethoxy-2-tosylphenyl)-2-(4-ethoxyphenyl)diazene (3q). Obtained as a white solid in 83% yield; M.p. 95–96 °C. 1H NMR (500 MHz, CDCl3) δ 7.91 (d, J = 2.7 Hz, 1H), 7.86 (d, J = 8.3 Hz, 2H), 7.79 (d, J = 8.9 Hz, 2H), 7.69 (d, J = 8.9 Hz, 1H), 7.19 (d, J = 8.1 Hz, 2H), 7.16–7.13 (m, 1H), 7.02–6.99 (m, 2H), 4.23 (q, J = 7.0 Hz, 2H), 4.16 (d, J = 7.0 Hz, 2H), 2.34 (s, 3H), 1.52 (d, J = 6.9 Hz, 3H), 1.49 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 161.77, 160.33, 147.13, 143.71, 142.76, 140.11, 139.61, 129.22, 128.07, 125.53, 120.75, 118.35, 114.60, 113.75, 64.55, 63.90, 21.53, 14.77, 14.65. HRMS (ESI+): calculated for C23H24N2O4S: [M + H]+ 425.153, found 425.0923.
(E)-1-(5-Methoxy-2-tosylphenyl)-2-(3-methoxyphenyl)diazene (3r). Obtained as a orange solid in 85% yield; M.p. 139–140 °C. 1H NMR (500 MHz, CDCl3) δ 8.33 (d, J = 8.7 Hz, 1H), 7.85 (d, J = 8.3 Hz, 2H), 7.55–7.49 (m, 1H), 7.45 (t, J = 8.0 Hz, 1H), 7.41–7.38 (m, 1H), 7.18 (d, J = 8.1 Hz, 2H), 7.14–7.08 (m, 3H), 3.93 (s, 3H), 3.90 (s, 3H), 2.33 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 164.15, 160.33, 153.79, 150.71, 143.56, 140.06, 131.45, 130.97, 129.82, 129.31, 127.80, 118.86, 118.10, 116.19, 106.73, 101.29, 55.98, 55.56, 21.51. HRMS (ESI+): calculated for C21H20N2O4S: [M + H]+ 397.1217, found 397.0627.
(E)-1-(3-Methoxyphenyl)-2-(2-tosylphenyl)diazene (3s). Obtained as a orange solid in 15% yield; M.p. 73–74 °C. 1H NMR (500 MHz, CDCl3) δ 8.39 (dd, J = 7.7, 1.5 Hz, 1H), 7.85 (d, J = 8.3 Hz, 2H), 7.70–7.61 (m, 2H), 7.58 (dd, J = 7.7, 1.4 Hz, 1H), 7.50–7.42 (m, 2H), 7.37 (dd, J = 5.0, 3.1 Hz, 1H), 7.17 (d, J = 8.0 Hz, 2H), 7.12–7.07 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 160.42, 149.01, 143.93, 139.37, 138.70, 137.02, 134.38, 130.58, 129.80, 129.46, 129.35, 128.12, 118.76, 117.98, 116.93, 106.76, 55.56, 21.55. HRMS (ESI+): calculated for C20H18N2O3S: [M + H]+ 367.1111, found 367.0548.
(E)-1-(5-Methoxy-2-tosylphenyl)-2-phenyldiazene (3t). Obtained as a orange solid in 71% yield; M.p. 70–71 °C. 1H NMR (500 MHz, CDCl3) δ 8.32 (d, J = 8.7 Hz, 1H), 7.84–7.79 (m, 4H), 7.55–7.50 (m, 3H), 7.15 (d, J = 8.1 Hz, 2H), 7.12–7.07 (m, 2H), 3.89 (s, 3H), 2.31 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 164.13, 152.57, 150.71, 143.54, 140.00, 132.05, 131.36, 131.11, 129.23, 129.12, 127.94, 123.84, 116.15, 101.22, 55.97, 21.51. HRMS (ESI+): calculated for C20H18N2O3S: [M + H]+ 367.1111, found 367.0548.
(E)-1-(5-Methoxy-2-tosylphenyl)-2-(m-tolyl)diazene (3u). Obtained as a orange solid in 81% yield; M.p. 70–71 °C. 1H NMR (500 MHz, CDCl3) δ 8.32 (d, J = 8.8 Hz, 1H), 7.83 (d, J = 8.3 Hz, 2H), 7.65 (d, J = 7.8 Hz, 1H), 7.58 (s, 1H), 7.41 (t, J = 7.7 Hz, 1H), 7.34 (d, J = 7.5 Hz, 1H), 7.17 (d, J = 8.3 Hz, 2H), 7.10 (dd, J = 8.8, 2.6 Hz, 1H), 7.07 (d, J = 2.6 Hz, 1H), 3.89 (s, 3H), 2.47 (s, 3H), 2.33 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 164.14, 152.67, 150.79, 143.48, 140.06, 138.98, 132.84, 131.35, 130.95, 129.22, 128.92, 127.89, 123.93, 121.57, 116.04, 101.19, 55.95, 21.53, 21.37. HRMS (ESI+): calculated for C21H20N2O3S: [M + H]+ 381.1267, found 381.0685.

Acknowledgements

This work was supported by the Zhejiang Provincial Natural Science Foundation of China (no. LZ13B020001), National Natural Science Foundation of China (no. 21376058) and Major scientific and technological innovation projects of Hangzhou City (no. 20122511A43).

Notes and references

  1. (a) G. Y. Song, F. Wang and X. W. Li, Chem. Soc. Rev., 2012, 41, 3651–3678 RSC; (b) Y. Fall, H. Doucet and M. Santelli, ChemSusChem, 2009, 2, 153–157 CrossRef CAS PubMed; (c) H. Y. Fu, L. Chen and H. Doucet, J. Org. Chem., 2012, 77, 4473–4478 CrossRef CAS PubMed; (d) A. M. Sajith and A. Muralidharan, Tetrahedron Lett., 2012, 53, 5206–5210 CrossRef CAS PubMed; (e) A. M. Sajith and A. Muralidharan, Tetrahedron Lett., 2012, 53, 1036–1041 CrossRef CAS PubMed; (f) H. Cao, Y. G. Lin, H. Y. Zhan, Z. D. Du, X. L. Lin, Q. M. Liang and H. Zhang, RSC Adv., 2012, 2, 5972–5975 RSC; (g) A. Nova, R. Mas-Balleste and A. Liedos, Organometallics, 2012, 31, 1245–1256 CrossRef CAS; (h) Y. S. Qiu, Y. Y. Kuang and J. Wu, Adv. Synth. Catal., 2014, 356(17), 3483–3504 CrossRef PubMed.
  2. (a) C. P. David, A. L. M. Geibel, E. M. N. J. Klein and R. Tobias, J. Am. Chem. Soc., 2009, 131, 17050–17051 CrossRef PubMed; (b) M. JoyRacowski, R. D. Allison and S. S. Melanie, J. Am. Chem. Soc., 2009, 131, 10974–10983 CrossRef PubMed.
  3. Z. Y. Wu, H. Y. Song, X. L. Cui, C. Pi, W. W. Du and Y. J. Wu, Org. Lett., 2013, 15(6), 1270–1273 CrossRef CAS PubMed.
  4. P. M. Liu and G. F. Christopher, Org. Lett., 2013, 15(22), 5862–5865 CrossRef CAS PubMed.
  5. H. Sun, C. M. Wang, Y. F. Yang, P. Chen, Y. D. Wu and X. H. Zhang, J. Org. Chem., 2014, 79(24), 11863–11872 CrossRef CAS PubMed.
  6. (a) R. D. Allison, L. H. Kami and S. S. Melanie, J. Am. Chem. Soc., 2004, 126, 2300–2301 CrossRef; (b) X. F. Cong and X. M. Zeng, Org. Lett., 2014, 16, 3716–3719 CrossRef CAS PubMed.
  7. S. P. Shi and C. X. Kuang, J. Org. Chem., 2014, 79, 6105–6112 CrossRef CAS PubMed.
  8. H. Tang, C. Qian, D. E. Lin, H. F. Jiang and W. Zeng, Adv. Synth. Catal., 2014, 356, 519–527 CrossRef CAS PubMed.
  9. H. Y. Song, D. Chen, C. Pi, X. L. Cui and Y. J. Wu, J. Org. Chem., 2014, 79, 2955–2962 CrossRef CAS PubMed.
  10. M. L. Yi, X. L. Cui, C. W. Zhu, C. Pi, W. M. Zhu and Y. Wu, Asian J. Org. Chem., 2015, 4, 38–41 CrossRef CAS PubMed.
  11. (a) H. J. Li, P. H. Li, Q. Zhao and L. Wang, Chem. Commun., 2013, 49, 9170–9172 RSC; (b) Z. Y. Li, D. D. Li and G. W. Wang, J. Org. Chem., 2013, 78, 10414–10420 CrossRef CAS PubMed.
  12. Z. W. Yin, X. Q. Jiang and P. P. Sun, J. Org. Chem., 2013, 78, 10002–10007 CrossRef CAS PubMed.
  13. (a) D. B. Zhao, Q. Wu, X. L. Huang, F. J. Song, T. Y. Lv and J. S. You, Chem. Eur. J, 2013, 19, 6239–6244 CrossRef CAS PubMed; (b) W. J. Han, G. Y. Zhang, G. X. Li and H. M. Huang, Org. Lett., 2014, 16, 3532–3535 CrossRef CAS PubMed; (c) M. Krishnamoorthy and C. H. Cheng, Chem.–Eur. J., 2013, 19, 6198–6202 CrossRef PubMed.
  14. C. Ian, D. E. Lin, Y. F. Deng, X. Q. Zhang, H. F. Jiang, G. Miao, X. H. Tang and W. Zeng, Org. Biomol. Chem., 2014, 12, 5866–5875 Search PubMed.
  15. X. F. Jia and J. Han, J. Org. Chem., 2014, 79, 4180–4185 CrossRef CAS PubMed.
  16. S. Miyamura, H. Tsurugi, T. Satoh and M. Miura, J. Organomet. Chem., 2008, 693, 2438–2442 CrossRef CAS PubMed.
  17. (a) L. Regina, A. Coluccia, A. Brancale, F. Piscitelli, V. Gatti, G. Maga, A. Samuele, C. Pannecouque, D. Schols, J. Balzarini, E. Novellino and R. Silvestri, J. Med. Chem., 2011, 54, 1587 CrossRef PubMed; (b) S. F. Barbuceanu, G. L. Almajan, I. Saramet, C. Draghici, A. I. Tarcomnicu and G. Bancescu, Eur. J. Med. Chem., 2009, 44, 4752 CrossRef CAS PubMed; (c) D. P. Becker, T. E. Barta, L. J. Bedell, T. L. Boehm, B. R. Bond, J. Carroll, C. P. Carron, G. A. Decrescenzo, A. M. Easton, J. N. Freskos, C. L. Funckes-Shippy, M. Heron, S. Hockerman, C. P. Howard, J. R. Kiefer, M. H. Li, K. J. Mathis, J. J. McDonald, P. P. Mehta, G. E. Munie, T. Sunyer, C. A. Swearingen, C. I. Villamil, D. Welsch, J. M. Williams, Y. Yu and J. Yao, J. Med. Chem., 2010, 53, 6653 CrossRef CAS PubMed; (d) E. Nuti, L. Panelli, F. Casalini, S. I. Avramova, E. Orlandini, S. Santamaria, S. Nencetti, T. Tuccinardi, A. Martinelli, G. Cercignani, N. D'Amelio, A. Maiocchi, F. Uggeri and A. Rossello, J. Med. Chem., 2009, 52, 6347 CrossRef CAS PubMed; (e) K. G. Liu, A. J. Robichaud, R. C. Bernotas, Y. Yan, J. R. Lo, M. Y. Zhang, Z. A. Hughes, C. Huselton, G. M. Zhang, J. Y. Zhang, D. M. Kowal, D. L. Smith, L. E. Schechter and T. A. Comery, J. Med. Chem., 2010, 53, 7639 CrossRef CAS PubMed; (f) A. V. Ivachtchenko, E. S. Golovina, M. G. Kadieva, V. M. Kysil, O. D. Mitkin, S. E. Tkachenko and I. M. Okun, J. Med. Chem., 2011, 54, 8161 CrossRef CAS PubMed; (g) S. Crosignani, A. Pretre, C. J. Lebrun, G. Fraboulet, J. Seenisamy, J. K. Augustine, M. Missotten, Y. Humbert, C. Cleva, N. Abla, H. Daff, O. Schott, M. Schneider, F. B. Charvillon, D. Rivron, I. Hamernig, J. F. Arrighi, M. Gaudet, S. C. Zimmerli, P. Juillard and Z. Johnson, J. Med. Chem., 2011, 54, 7299 CrossRef CAS PubMed.
  18. (a) F. Colobert, G. R. Ballesteros, F. R. Leroux, R. Ballesteros and B. Abarca, Tetrahedron Lett., 2007, 48, 6896 CrossRef CAS PubMed; (b) I. P. Beletskaya and V. P. Ananikov, Chem. Rev., 2011, 111, 1596 CrossRef CAS PubMed; (c) C. C. Eichman and J. P. Stambuli, Molecules, 2011, 16, 590 CrossRef CAS PubMed; (d) C. P. Zhang and D. A. Vicic, J. Am. Chem. Soc., 2012, 134, 183 CrossRef CAS PubMed; (e) J. M. Khurana, V. Sharma and S. A. Chacko, Tetrahedron, 2007, 63, 966 CrossRef CAS PubMed; (f) A. Costa, C. Najera and J. M. Sansano, J. Org. Chem., 2002, 67, 5216 CrossRef CAS PubMed.
  19. (a) C. A. Zificsak and D. J. Hlasta, Tetrahedron, 2004, 60, 8991 CrossRef CAS PubMed; (b) K. C. Nicolaou, P. G. Bulger and D. Sarlah, Angew. Chem., Int. Ed., 2005, 44, 4442 CrossRef CAS PubMed; (c) B. Ligault, I. Petrov, S. I. Gorelsky and K. Fagnou, J. Org. Chem., 2010, 75, 1047 CrossRef PubMed; (d) Y. J. Cheng, S. H. Yang and C. S. Hsu, Chem. Rev., 2009, 109, 5868 CrossRef CAS PubMed.
  20. Y. F. Xu, P. Liu, S. L. Li and P. P. Sun, J. Org. Chem., 2015, 80, 1269–1274 CrossRef CAS PubMed.
  21. O. Saidi, J. Marafie, A. E. W. Ledger, P. M. Liu, M. F. Mahon, K. K. Gabriele, M. K. Whittlesey and C. G. Frost, J. Am. Chem. Soc., 2011, 133, 19298–19301 CrossRef CAS PubMed.
  22. X. D. Zhao, E. Dimitrijević and V. M. Dong, J. Am. Chem. Soc., 2009, 131, 3466–3467 CrossRef CAS PubMed.
  23. D. Zhang, X. L. Cui, Q. Q. Zhang and Y. J. Wu, J. Org. Chem., 2015, 80, 1517–1522 CrossRef CAS PubMed.
  24. (a) C. Shen, H. J. Xia, H. Yan, X. Z. Chen, S. Ranjit, D. Tan, R. Lee, K. W. Huang, P. F. Zhang and X. G. Liu, Chem. Sci., 2012, 3, 2388–2393 RSC; (b) C. Shen, J. Xu, W. B. Yu and P. F. Zhang, Green Chem., 2014, 16, 3007–3012 RSC; (c) C. Shen, P. F. Zhang, Q. Sun, S. Q. Bai, T. S. A. Hor and X. G. Liu, Chem. Soc. Rev., 2015, 44, 291–314 RSC; (d) C. Shen, H. Y. Shen, M. Yang, C. C. Xia and P. F. Zhang, Green Chem., 2015, 17, 225–230 RSC; (e) H. Y. Shen, C. Shen, A. M. Wang and P. F. Zhang, Catal. Sci. Technol., 2015, 5, 2065–2071 RSC.

Footnote

Electronic supplementary information (ESI) available: 1H NMR spectra, 13C NMR spectrum, GC/MS profile, HRMS profile. CCDC 1057250. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5ra06474k

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.